|
glutathione
|
CHEBI_16856 |
[A tripeptide compound consisting of glutamic acid attached via its side chain to the N-terminus of cysteinylglycine.] |
|
docosahexaenoic acid
|
CHEBI_36005 |
[Any C22 polyunsaturated fatty acid containing six double bonds.] |
|
site of polarized growth
|
GO_0030427 |
[Any part of a cell where non-isotropic growth takes place.] |
|
omega-6 fatty acid
|
CHEBI_36009 |
[A family of polyunsaturated fatty acids that have in common a final carbon-carbon double bond in the n-6 position, i.e., the sixth bond from the methyl end of the fatty acid.] |
|
single blinded study
|
ERO_0000357 |
[An interventional study in which the person collecting the data knows whether the subjects are in the control or experimental groups but the subjects do not.] |
|
double blinded study
|
ERO_0000358 |
[An interventional study in which neither the subjects of the experiment nor the persons administering the experiment know the critical aspects of the experiment; a double-blind procedure is used to guard against both experimenter bias and placebo effects.] |
|
continuant
|
BFO_0000002 |
[An entity that exists in full at any time in which it exists at all, persists through time while maintaining its identity and has no temporal parts.] |
|
entity
|
BFO_0000001 |
|
|
occurrent
|
BFO_0000003 |
|
|
Thing
|
Thing |
|
|
proteolytic cleavage product
|
PR_000018264 |
[A protein that is produced as the result of proteolytic processing of a longer protein.] |
|
sesquiterpenoid
|
CHEBI_26658 |
[Any terpenoid derived from a sesquiterpene. The term includes compounds in which the C15 skeleton of the parent sesquiterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).] |
|
Proportion
|
NCIT_C49159 |
[A part, fraction, share, or number considered in relation to the whole amount or number.] |
|
3-disulfanyl-L-alanine
|
CHEBI_28839 |
[An S-substituted L-cysteine where the S-substituent is specified as sulfanyl.] |
|
prostaglandin E2
|
CHEBI_15551 |
[Prostaglandin F2alpha in which the hydroxy group at position 9 has been oxidised to the corresponding ketone. Prostaglandin E2 is the most common and most biologically potent of mammalian prostaglandins.] |
|
spatial region
|
BFO_0000006 |
|
|
prostaglandin H2
|
CHEBI_15554 |
|
|
two-dimensional spatial region
|
BFO_0000009 |
|
|
transcription, DNA-templated
|
GO_0006351 |
[The cellular synthesis of RNA on a template of DNA.] |
|
CD36
|
OGG_3000000948 |
|
